300966.SZ
Price:
$18.99
Market Cap:
$2.19B
Hubei Goto Biopharm Co.,Ltd. engages in the production and sale of steroid hormone API's and intermediates in China. It offers starting materials, such as 9a-hydroxy-4-androstenedione(9a-OHAD), bisnoralcohol(BA), sitolactone, 1.4-androstadienedione(ADD), and 4-androstenedione(4-AD); intermediates, including estrogens, progesterone, nonsteroids, other hormones, and corticosteroids; and other pharmaceutical raw materials. The company was founded in 2006 and is based in Yicheng, China.
Industry
Biotechnology
IPO Date
2021-04-09
Stock Exchange
SHZ
Ticker
300966.SZ
According to Hubei Goto Biopharm Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -3.22%. This represents a change of 300.77% compared to the average of -0.80% of the last 4 quarters.
The mean historical ROE of Hubei Goto Biopharm Co.,Ltd. over the last ten years is 8.96%. The current -3.22% ROE has changed -135.95% with respect to the historical average. Over the past ten years (40 quarters), 300966.SZ's ROE was at its highest in in the June 2020 quarter at 4.18%. The ROE was at its lowest in in the December 2024 quarter at -1.45%.
Average
8.96%
Median
9.84%
Minimum
-2.99%
Maximum
17.31%
Discovering the peaks and valleys of Hubei Goto Biopharm Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.65%
Maximum Annual ROE = 17.31%
Minimum Annual Increase = -223.78%
Minimum Annual ROE = -2.99%
Year | ROE | Change |
---|---|---|
2024 | -2.99% | -223.78% |
2023 | 2.41% | -44.26% |
2022 | 4.33% | -55.37% |
2021 | 9.71% | -2.64% |
2020 | 9.97% | -34.28% |
2019 | 15.17% | -12.39% |
2018 | 17.31% | 9.65% |
The current ROE of Hubei Goto Biopharm Co.,Ltd. (300966.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.25%
5-year avg
4.69%
10-year avg
8.96%
Hubei Goto Biopharm Co.,Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hubei Goto Biopharm Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hubei Goto Biopharm Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Hubei Goto Biopharm Co.,Ltd.'s ROE?
How is the ROE calculated for Hubei Goto Biopharm Co.,Ltd. (300966.SZ)?
What is the highest ROE for Hubei Goto Biopharm Co.,Ltd. (300966.SZ)?
What is the 3-year average ROE for Hubei Goto Biopharm Co.,Ltd. (300966.SZ)?
What is the 5-year average ROE for Hubei Goto Biopharm Co.,Ltd. (300966.SZ)?
How does the current ROE for Hubei Goto Biopharm Co.,Ltd. (300966.SZ) compare to its historical average?